Sector Experts

Subscribe to
Streetwise Reports

Ask this Expert

Companies Commented On

Jim Letourneau

Big Picture Speculator

Image: Jim Letourneau

Jim Letourneau is the founder and editor of the Big Picture Speculator and is a geologist living in Calgary, Alberta. He is an early-stage investor in energy, metals, biotech and technology companies. He speaks at investment conferences across North America.




Recent Interviews

Fracking, Uranium and Solar, Oh My!: Growth and Innovation in 2013 (12/26/13) A more profitable outcome often requires a new way of doing things. The Energy Report profiled some of the most innovative stories in the energy space in 2013. Our experts talked about everything from developments in hydraulic fracturing techniques to new ways of finding and processing natural resources. As we look forward to exciting new opportunities in 2014, let's revisit some stories our experts shared last year.

Adventures in the Biotech Trade with Jim Letourneau (8/15/13) Jim Letourneau, publisher of Big Picture Speculator, shares tales of strange biotechnologies worth buying into—such as cures for high dental bills and dog breath—in this interview with The Life Sciences Report. Letourneau likes to invest in biotech firms because their stock values are less volatile than commodity-based companies, which are chained to uncontrollable price fluctuations. You are advised to hold onto your brain (quite literally), while Letourneau describes a few curious—and potentially profitable—biotech investment adventures.

Smart Fracking: Jim Letourneau on Enhanced Oil Recovery with Competitive Costs (8/8/13) What's the difference between an oil well and a very expensive hole in the ground? Advanced hydraulic fracturing techniques, in many cases. That's why Big Picture Speculator Editor Jim Letourneau is following service companies that are helping producers get to the finish line on time and under budget. In this interview with The Energy Report, Letourneau discusses new ways to play the ever-evolving shale revolution.

Recent Quotes

"ONCY's Reolysin reovirus can inject into tumors to kill cancerous cells." (8/15/13) Oncolytics Biotech Inc. - The Life Sciences Report Interview with Jim Letourneau More >

"VRS has an amazing, game-changing device that detects skin cancer with good accuracy." (8/15/13) Verisante Technology Inc. - The Life Sciences Report Interview with Jim Letourneau More >

"BTI's Transcend technology allows drugs to cross the blood-brain barrier, which is a big issue for treating brain disease." (8/15/13) biOasis Technologies Inc. - The Life Sciences Report Interview with Jim Letourneau More >

"BSP has a big land position with a foot in the Wolfberry door." (8/8/13) Big Sky Petroleum Corp. - The Energy Report Interview with Jim Letourneau More >

"ZEX has a big land package in California's San Joaquin Basin and has farmed some of it out." (8/8/13) Zodiac Exploration Inc. - The Energy Report Interview with Jim Letourneau More >

"I think everyone is expecting BSP's share value to grow." (4/25/13) Big Sky Petroleum Corp. - The Energy Report Interview with Jim Letourneau More >

"URE just closed a $5.1M transaction that provides upfront cash in return for future uranium deliveries." (4/25/13) Ur-Energy Inc. - The Energy Report Interview with Jim Letourneau More >

"VRS' platform is very compelling." (1/17/13) Verisante Technology Inc. - The Life Sciences Report Interview with Jim Letourneau More >

more comments

"Big pharma is interested in BTI." (1/17/13) biOasis Technologies Inc. - The Life Sciences Report Interview with Jim Letourneau More >

"RVX is busily building an intellectual property fence around the proteins it has been working on." (1/17/13) Resverlogix Corp. - The Life Sciences Report Interview with Jim Letourneau More >

"ONCY is a good example of a company with good prospects in 2013." (1/17/13) Oncolytics Biotech Inc. - The Life Sciences Report Interview with Jim Letourneau More >

fewer comments


Due to permission requirements, not all quotes are shown.